This federal contract award, with ID SPE2DB22D3019|SPE2DB25FK3EU, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,001.30 firm-fixed-price delivery order is for the supply of 4567441444 ! ABIRATERONE ACETATE 500 MG TAB 60S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,182.10 firm fixed-price delivery order contract is for the supply of 4,565,950,374 units of abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of September 27, 2024. This delivery order is issued under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,822.78 firm fixed price delivery order is for the supply of 4565133468 Abiraterone Acetate 250 mg tablets. The contract has a ceiling value of $1,822.78 and a completion date of July 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,016.18, is a delivery order for the supply of Abiraterone Acetate 500 mg tablets. It is a firm fixed-price contract with a performance period ending on May 14, 2025. The contract is not designated as a set-aside and was awarded through open competition. AmerisourceBergen Drug Corp is the prime...
This contract award, with ID SPE2DB22D3501|SPE2DB25FTG77, is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,667.28 firm-fixed-price contract is for the delivery of 4,566,216,846 units of abiraterone acetate 250 mg tablets by October 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,930.76 firm fixed-price delivery order contract is for the supply of 4564792490 abiraterone acetate 250 mg tablets. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.68 Firm Fixed Price Delivery Order is for the supply of Abiraterone Acetate 250 mg tablets. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, SPE2DB22D3004|SPE2DB25FNX40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,896.33 Firm Fixed Price Delivery Order contract covers the supply of Abiraterone Acetate 250 mg tablets with an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of abiraterone acetate 250 mg tablets. The contract has a ceiling value of $1,610.20 and a completion date of February 26, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,968.55 Firm Fixed Price delivery order contract is for the supply of Abiraterone Acetate 500 mg tablets, a medication used in the treatment of prostate cancer. The contract has an ultimate completion date of January 13, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999...